Telehealth is revolutionizing longevity medicine by expanding access to preventative care and increasing consumer demand for treatments like GLP-1s and rapamycin. Despite insurance challenges, telehealth's integration with AI and digital tools empowers patients to bypass traditional healthcare barriers, enhancing both research and accessibility.

The World Health Organization anticipates dementia cases will nearly triple by 2050, with aging as a primary driver. New research highlights the link between aging and Alzheimer's, emphasizing the need for targeted interventions.

A Johns Hopkins study shows even minimal amounts of exercise significantly cut dementia risk in older adults. Published in January 2025, the study stresses that lifestyle changes are key to dementia prevention.

Avio Health, an AI-driven biomarker analytics platform, is revolutionizing longevity medicine by streamlining medical data analysis, currently used at Emagene Life in Kuala Lumpur. Co-founder Dr. Elvin Siew emphasizes its potential to enhance diagnostic accuracy and efficiency, attracting interest from global healthcare providers.

Senescent cells are pivotal in aging, promoting immune senescence through their immunosuppressive phenotype and SASP, leading to chronic inflammation. They also evade immune detection via inhibitory checkpoint pathways, complicating immune responses.

Katherine Kelly Lang, celebrated for her enduring role as Brooke Logan on 'The Bold and The Beautiful,' underscores the pressures of Hollywood while advocating for health and positivity. At 63, she champions strength training, a healthy lifestyle, and a supportive work environment as keys to longevity in the youth-focused entertainment industry.

Shift Bioscience has established a new team and facilities in Toronto to enhance its AI-driven virtual cell technology for age-related disease treatment. Led by Lucas Camillo and advised by AI expert Bo Wang, the expansion taps into North America's AI talent and aims to accelerate the discovery of rejuvenation gene targets.

A new study in the Annals of Neurology links low active vitamin B12 levels with cognitive decline, despite normal overall levels. Researchers suggest redefining B12 deficiency and considering supplements for older adults.

Longevity.Technology has launched FLT MUSCLE, a supplement with PeptiStrong from fava beans, addressing age-related muscle loss. Clinical trials show it enhances muscle recovery and energy over milk protein.

Doug Whitney, 75, defies genetic odds by remaining symptom-free of early Alzheimer's despite a mutation linked to the disease. His case, involving unique genetic and environmental factors like heat exposure, offers potential insights for Alzheimer's research, although experts advise caution until further studies are conducted.

A study in Molecular Neurodegeneration reveals distinct retinal aging patterns across nine mouse strains, highlighting genetic variability akin to humans. This research aids in understanding eye diseases and neurodegenerative risks, emphasizing the need for diverse models in aging studies.

Loss of adenosine receptor signaling is linked to age-related diseases affecting skin, musculoskeletal, and vascular systems, highlighting its crucial role in cellular health. The study suggests targeting adenosine receptors could open new therapeutic avenues for aging-related conditions, as population aging continues to rise in the U.S.

The Global Healthspan Summit 2025 in Riyadh, hosted by Hevolution Foundation, became the world's largest longevity conference, with over 3,000 attendees focusing on healthspan over lifespan. Key discussions included advances in aging biomarkers, mammalian longevity, and the role of bioelectricity in regenerative medicine.

Chi Longevity has introduced 'Chi Longevity with Sparkd,' the world's first evidence-based healthy longevity gym, in Singapore. This initiative integrates medical diagnostics with cognitive and physical training, aiming to enhance brain function and address aging across all age groups.

Longevity.Technology has launched FLT COGNITION, a supplement aimed at boosting mental clarity and brain health. It features Blue California's ErgoActive® L-Ergothioneine, known for its antioxidant benefits.

NaturalX Health Ventures has launched a €100 million fund to support early-stage consumer health startups in Europe, leveraging Schwabe Group's pharmaceutical expertise. The fund targets Series A investments in areas like sleep and mental health, aiming to replicate U.S. market success in Europe.

The upcoming Fight Aging! newsletter spotlights research targeting Alzheimer's and neurodegenerative diseases, emphasizing the role of amyloid-β production and gut health in disease progression. It also discusses innovative approaches like drug repurposing for myelin repair and strategies to mitigate cancer spread, highlighting the intersection of modern medicine and aging.

X-Therma's cutting-edge cryopreservation technology could revolutionize organ transplants by extending preservation times beyond current limits. This innovation is critical amid a persistent organ shortage crisis, with over 103,000 U.S. patients still waiting for transplants despite 46,000 performed in 2023.

Junevity, a San Francisco biotech startup, has secured $10 million in seed funding to develop 'cell reset' therapies targeting age-related diseases. Led by Goldcrest and Godfrey Capital, this investment will help advance clinical trials by 2026, focusing on conditions like Type 2 diabetes and obesity.